Susquehanna International Group’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History
Bought
Maintained
Sold
Other funds holding CANF
AC
SIA
SHIM
TWC
Susquehanna International Group's CANF Position: Q4 2023 in Review
Susquehanna International Group sold out of Can-Fite BioPharma American Depositary Shares (CANF) in Q4 2023, closing a stake of 602 shares — an estimated $31.9K sold.
Susquehanna International Group first reported a position in CANF in Q1 2014 and held it in 12 quarters. The position peaked at $1.47M in Q1 2014. 9 funds tracked by Wall St. Rank hold CANF as of Q4 2023.
- Susquehanna International Group reported no remaining Can-Fite BioPharma American Depositary Shares position as of Q4 2023 after selling out during the quarter.
- Susquehanna International Group sold 602 Can-Fite BioPharma American Depositary Shares shares in Q4 2023, an estimated $31.9K.
- Susquehanna International Group first reported a position in Can-Fite BioPharma American Depositary Shares in Q1 2014 and held it in 12 quarters.
- Susquehanna International Group's Can-Fite BioPharma American Depositary Shares position peaked at $1.47M in Q1 2014.
- 9 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q4 2023.
Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.